Oxidative stress induced in rat brain by a combination of 3-nitropropionic acid and global ischemia

International Journal of Clinical and Experimental Medicine

Volumn 3, Issue 2, 2010, Pages 144-151

  Dobrota, Dusan ^a   Fedorova, Tatiana N ^b   Stepanova, Maria S ^b   Babusikova, Eva ^a   Statelova, Dagmar ^a   Tatarkova, Zuzana ^a   Stvolinsky, Sergey S ^b   Boldyrev, Alexander A ^b,c  

^a University Hospital in Martin   (Slovakia)

^b RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

3 nitropropionic acid; Brain global ischemia; Carnosine; Oxidative stress

Indexed keywords

3 NITROPROPIONIC ACID; CARNOSINE; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; ENERGY METABOLISM; MALE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; SYMPTOM;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77955528672     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Akopian G, Crawford C, Beal MF, Cappelletti M, Jakowec WM, Petzinger GM, Zheng L, Gheorghe SL, Reichel CM, Chow R, and Walsh JP. Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3 -nitropropionic-acid-induced chemical hypoxia. J. Neurosci 2008; 28: 9585-9597.
2. Boldyrev AA. Carnosine is a natural antioxidant and neuroprotector: biological functions and possible clinical use. Free radicals, NO, and inflammation: Molecular, Biochemical and Clinical Aspects Edited by Tomasi A, Ozbren T. and Skulachev VP. IOS Press, 2003, pp. 203-217.
3. Boldyrev AA. Protection of proteins from oxidative stress: a new illusion or a novel strategy? Ann NY Acad Sci 2005 1057: 193-205.
4. Hossmann K-A. Experimental models for the investigation of brain ischemia. Cardiovasc Res 1998; 39: 106-120.
5. Pulsinelli WA, Brierley JV. A new model of bilateral hemispheric ischemia in the unanaesthetized rat. Stroke 1979; 10: 267-272.
6. Gallant S, Kukley M, Stvolinsky S, Bulygina E, Boldyrev A. Effect of carnosine on rats under experimental brain ischemia. Tohoku J Exp Med 2000; 191: 85-99.
7. Fedorova TN, Stvolinsky SL, Dobrota D, Boldyrev AA. Therapeutical effects of carnosine in experimental brain ischemia. Problems Biol Med Pharm Chem (in Russian) 2002; 1: 41-44.
8. del Zoppo GJ. Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow. J Int Med 1995; 237: 79-88.
9. Grotta J. Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy. J Int Med 1995; 237: 89-94.
10. Dobrota D, Fedorova T, Stvolinsky S, Babusikova E, Likavcanova K, Drgova A, Strapkova A, Boldyrev A. Carnosine protects the brain of rats and mongolian gerbils against ischemic Injury: After-Stroke-Effect. Neurochem Res 2005; 30 (10): 1283-1288.
11. Beal MF. Neurochemistry and toxin models in Huntington's disease. Curr Opin Neurol 1994; 7: 542-547.
12. Guyot MC, Hantaraye P, Dolan R, Palfi S, Maziere M, Brouillet E. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatum lesions in rats chronically treated with 3 -nitropropionic acid. Neuroscience 1997; 79: 45-56.
13. Maragos WF, Tillman PA, Jakel RJ. Chlorgyline and deprenyl attenuate striatal malonate and 3- nitropropionic acid. Brain Research 1999; 834: 168-172.
14. Borlongan CV, Koutouzis TK, Randall TS, Freeman TB, Cahill DW, and Sanberg PR. Systemic 3- NPA: Behavioral deficits and striatal damage in adult rats. Brain Res Bull 1995; 36(6): 549-556.
15. Andreassen OA, Ferrante RJ, Hughes DB, Klivenyi P, Dedeoglu A, Ona VO, Frielander RM, Beal MF. Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant. J Neurochem 2000; 75: 847-852.
16. Boldyrev AA, Song R, Lawrence D, Carpenter DO. Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species. Neuroscience 1999; 94: 571-577.
17. Dodd PR, Hardy JA, Oakley AE, Edwardson JA, Perry EK, and Delaunoy JP. A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res 1981; 226 (1-2): 107-118.
18. Misra HP, Fridovich J. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. Biochemistry 1972; 247: 3170-3175.
19. Powell CS, Jackson RM. Mitochondrial complex I, aconitase, and succinate dehydrogenase during hypoxia-reoxygenation: modulation of enzyme activities by Mn-SOD. Am J Physiol Lung Cell Mol Physiol 2003; 285: L189-L198.
20. Fedorova TN, Boldyrev AA, Gannushkina IV. Lipid peroxidation during experimental brain ischemia. Biochemistry (Moscow) 1999; 64: 94-98.
21. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193(1): 265-275.
22. Nakano S, Kogure K, Fujikura H. Ischemiainduced slowly progressive neuronal damage in the rat brain. Neuroscience 1990; 38(1): 115-124.
23. Lipton P. Ischemic Cell Death in Brain Neurons. Physiol Rev 1999; 79(4): 1431-1568.
24. Ghukasyan TG, Petrosyan AA, Shirinyan ME, Shirinyan EA. Catecholaminergic system of the brain during ischemia. Neurochemistry (Moscow) 2000; 17(1): 13-22.
25. Fu YT, He FS, Zhang SL, Zhang JS. Lipid peroxidation in rats intoxicated with 3-nitropropionic acid. Toxicon 1995; 33(3): 327-331.
26. Binienda ZK, Ali SF. Neuroprotective role of L- carnitine in the 3-nitropropionic acid induced neurotoxicity. Toxicol Lett 2001; 125(1-3): 67-73.
27. McCracken E, Dewar D, and Hunter AJ. White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat. Brain Res 2001; 892(2): 329-335.